Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Hims & Hers will stop selling some weight loss drugs — and the stock plummets 27%
Hims & Hers (HIMS) stock took a steep dive, dropping more than 27%Tuesday morning — even after the millennial-focused ...
Bay Area startup, a few years after being bought for $131M, shuts down
Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...
Hims & Hers: The Odds Are In Your Favor, Here's How To Take Advantage (Rating Upgrade)
Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.
AOL14d
Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
The figure excludes contributions from semaglutide drugs, which will not be offered after the first quarter, Okupe said. Hims launched in 2017, selling generic hair loss, sexual health ...
This Could Be a Huge Blow to Hims & Hers Health Stock
Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...
Healthline11d
Best Products for Hair Growth in 2025
After setting up a Hims account ... hypothyroidism, postpartum hair loss, and alopecia, have shared promising before and after photos. Many positive reviewers note getting results in as little ...